Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
F. Javier Álvarez. (2016) Parkinson’s disease, antiparkinson medicines, and driving. Expert Review of Neurotherapeutics 16:9, pages 1023-1032.
Read now
Read now
Ruxandra Julia Vorovenci & Angelo Antonini. (2015) The efficacy of oral adenosine A2A antagonist istradefylline for the treatment of moderate to severe Parkinson’s disease. Expert Review of Neurotherapeutics 15:12, pages 1383-1390.
Read now
Read now
Articles from other publishers (15)
Yuxin Huang. (2023) A review on the current status and development of Parkinson's clinical drugs. A review on the current status and development of Parkinson's clinical drugs.
Yuemei Wang, Yuanbing Zhu, Junmeng Wang, Longcong Dong, Shuqing Liu, Sihui Li & Qiaofeng Wu. (2023) Purinergic signaling: A gatekeeper of blood-brain barrier permeation. Frontiers in Pharmacology 14.
Crossref
Crossref
Xiaoqin Hu, Jinhuan Ni, Nanyong Gao, Zhize Ye, Guoxin Hu, Jianping Cai & Jianchang Qian. (2022) The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline. Chemico-Biological Interactions 366, pages 110123.
Crossref
Crossref
Ernesto Alberto Rendón-Ochoa, Montserrat Padilla-Orozco, Vladimir Melesio Calderon, Victor Hugo Avilés-Rosas, Omar Hernández-González, Teresa Hernández-Flores, María Belén Perez-Ramirez, Marcela Palomero-Rivero, Elvira Galarraga & José Bargas. (2022)
Dopamine D
2
and Adenosine A
2A
Receptors Interaction on Ca
2+
Current Modulation in a Rodent Model of Parkinsonism
. ASN Neuro 14, pages 175909142211020.
Crossref
Crossref
Min Shin, Madhavi Pandya, Kristan Espinosa, Ravindra Telang, Jordi Boix, Peter R. Thorne & Srdjan M. Vlajkovic. (2021) Istradefylline Mitigates Age-Related Hearing Loss in C57BL/6J Mice. International Journal of Molecular Sciences 22:15, pages 8000.
Crossref
Crossref
Xiang Li, Wenjun Wang, Jianghong Yan & Fancai Zeng. (2021) Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease. Frontiers in Neuroscience 15.
Crossref
Crossref
Angela Valderrama Parizotto, Ana Paula Ferro, Rogério Marchiosi, Flávia Carolina Moreira-Vilar, Jennifer Munik Bevilaqua, Wanderley Dantas dos Santos, Flávio Augusto Vicente Seixas & Osvaldo Ferrarese-Filho. (2020) Entacapone improves saccharification without affecting lignin and maize growth: An in silico, in vitro, and in vivo approach. Plant Physiology and Biochemistry 151, pages 421-428.
Crossref
Crossref
Francisco M. Mouro, Attila Köfalvi, Luís A. André, Younis Baqi, Christa E. Müller, Joaquim A. Ribeiro & Ana M. Sebastião. (2019) Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism. Neuropharmacology 155, pages 10-21.
Crossref
Crossref
Marina Cerrone, Chantal J. M. van Opbergen, Kabir Malkani, Natasha Irrera, Mingliang Zhang, Toon A. B. Van Veen, Bruce Cronstein & Mario Delmar. (2018) Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression. Frontiers in Physiology 9.
Crossref
Crossref
Fabiana Núñez, Jaume Taura, Juan Camacho, Marc López-Cano, Víctor Fernández-Dueñas, Naomi Castro, Julio Castro & Francisco Ciruela. (2018) PBF509, an Adenosine A2A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers in Pharmacology 9.
Crossref
Crossref
Jaume Taura, Ernest G. Nolen, Gisela Cabré, Jordi Hernando, Lucia Squarcialupi, Marc López-Cano, Kenneth A. Jacobson, Víctor Fernández-Dueñas & Francisco Ciruela. (2018) Remote control of movement disorders using a photoactive adenosine A2A receptor antagonist. Journal of Controlled Release 283, pages 135-142.
Crossref
Crossref
Caio M. Massari, Marc López-Cano, Fabiana Núñez, Víctor Fernández-Dueñas, Carla I. Tasca & Francisco Ciruela. (2017) Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. Frontiers in Pharmacology 8.
Crossref
Crossref
Paulo A. de Oliveira, James A. R. Dalton, Marc López-Cano, Adrià Ricarte, Xavier Morató, Filipe C. Matheus, Andréia S. Cunha, Christa E. Müller, Reinaldo N. Takahashi, Víctor Fernández-Dueñas, Jesús Giraldo, Rui D. Prediger & Francisco Ciruela. (2017) Angiotensin II type 1/adenosine A
2A
receptor oligomers: a novel target for tardive dyskinesia. Scientific Reports 7:1.
Crossref
Crossref
Sergi Ferré. 2017. Adenosine Receptors in Neurodegenerative Diseases. Adenosine Receptors in Neurodegenerative Diseases
231
255
.
Lakshmi Jayashankar & Richard Hafner. (2016) Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination. Frontiers in Immunology 7.
Crossref
Crossref